EGFRvIII CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFRvIII CAR T cells, covering 2020-07-24 to 2020-07-24. Get the full timeline:
Most recent: Clinical Trial Update: EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma [Phase 1]